EDUSELL
Financial Market Examiner
Midas Crypto Vault
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews
No Result
View All Result
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews
No Result
View All Result
Financial Market Examiner
No Result
View All Result
Home Crypto News

Cancer Drug Company Accuses US Market Makers Of Stock Spoofing

Admin by Admin
December 2, 2022
in Crypto News
0
Cancer Drug Company Accuses US Market Makers Of Stock Spoofing
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter
MMC MMC

A cancer-focused biotechnology company has sued eight of the US’s largest market-making traders including Citadel Securities, Susquehanna and Virtual, alleging that they deliberately drove down its share price by placing sell orders they had no intention of executing.

The complaint, filed by Northwest Biotherapeutics in a federal court in New York on Thursday, claimed that the traders deliberately engaged in repeated spoofing that interfered with the natural forces of supply and demand” by placing tens of millions of fake orders between December 2017 and August of this year.

The trading companies would then cancel those orders and buy Northwest’s shares at an artificially lower price.

Lawyers for the clinical-stage biotechnology firm claimed a “particularly egregious example” of this activity took place in May, after the publication of what they maintain were positive trial data for Northwest’s DCVax-L brain cancer drug. The study’s design had been questioned by scientists.

The news “should have caused NWBO’s share price to increase, absent manipulation in the market”, they wrote, referring to the company’s stock symbol. Instead it dropped from $1.73 to a low of $0.3862.

“This staggering decline of 78 per cent in the price on a day with extremely positive news about the company was caused by defendants’ relentless and brazen manipulation of the market for NWBO shares,” lawyers at Cohen Milstein Sellers & Toll added.

However, the presentation of the DCVax clinical data was not well received by all commentators. “Overall, patients treated with DCVax had a 10 per cent higher risk of tumor progression compared to placebo — an outcome that is the antithesis of what’s required from any effective cancer treatment,” industry specialist publication STAT wrote at the time.

In March, the company had warned in regulatory submissions that “because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the company’s ability to continue as a going concern within one year from the date of this filing”.

Maryland-based Northwest Biotherapeutics has a market capitalisation of about $860mn and is traded on the US over-the-counter market. Its shares currently change hands at about $0.83.

In 2019 the company settled an action by the Securities and Exchange Commission after the regulator found it failed to maintain internal controls over its financial reporting for 12 years.

Aside from Citadel Securities, Susquehanna and Virtu, the lawsuit named Canaccord Genuity, GTS, Instinet, Lime Trading and Susquehanna subsidiary G1 as defendants.

In its complaint, Northwest said it sold 49mn of its shares at artificially deflated prices. It added that there was “an extremely low statistical likelihood” that the price variations in each of the alleged spoofing incidents had occurred due to normal market moves.

Share on TwitterTweet
Share on Pinterest Share
Share on LinkedIn Share
Share on Digg Share
Tags: CryptoStockstock spoofing
Institutional Trading Concept Institutional Trading Concept Institutional Trading Concept
ADVERTISEMENT
Previous Post

Apple Blocks App Update Over NFTs

Next Post

Binance Expands Into New Market Despite Crypto Market Meltdown

Admin

Admin

Next Post
Community Makes South Park Version Of CZ Binance

Binance Expands Into New Market Despite Crypto Market Meltdown

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

  • 99 Subscribers
  • Trending
  • Comments
  • Latest
AUD USD pair

Forex: AUD/USD Point To More Downside For The Aussie

October 20, 2022
yen and dollar

FOREX-Yen Flirts With Intervention Level As Dollar See Gains

October 11, 2022
Virtual stadium in the metaverse

Why Virtual Stadium Can Be the Next Big Thing in the Metaverse

January 26, 2023
USDD Depegs

USDD Stablecoin Depegs To $0.96, Tron (TRX) Dumped

December 12, 2022
What is Initial Coin Offering?

Initial Coin Offering (ICO)

0
What is staking?

Staking

0
What is Defi?

Defi (Decentralized Finance)

0
Differences between Axie Infinity and Decentraland

Axie Infinity and Decentraland: Features and Differences

0
What is Wiki Cat

What is Wiki Cat (WKC)?

February 1, 2023
FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

February 1, 2023
Tesla Lost Millions In Crypto

Tesla Lost Millions In Crypto

February 1, 2023
UK Treasury Publishes Crypto Framework Paper

UK Treasury Publishes Crypto Framework Paper

February 1, 2023

Recent News

What is Wiki Cat

What is Wiki Cat (WKC)?

February 1, 2023
FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

February 1, 2023
Tesla Lost Millions In Crypto

Tesla Lost Millions In Crypto

February 1, 2023
UK Treasury Publishes Crypto Framework Paper

UK Treasury Publishes Crypto Framework Paper

February 1, 2023
Financial Market Examiner

Get all the latest Financial Market (Crypto & Forex) news, updates and other relevant resources here.

Follow Us

Browse by Category

  • Crypto News
  • Education
  • Forex News
  • Gaming
  • Reviews
  • Stocks

Recent News

What is Wiki Cat

What is Wiki Cat (WKC)?

February 1, 2023
FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

FTX Group Interim Financial Update Contradicts Court Filing, Shows Exchange Had $1.43B In Cash

February 1, 2023

© 2022 Financial Market Examiner. - Designed by Mayconcept Solutions.

No Result
View All Result
  • Home
  • Education
  • Forex News
  • Crypto News
  • Stocks
  • Reviews

© 2022 Financial Market Examiner. - Designed by Mayconcept Solutions.

?>